Hormonal Therapy
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you your search results in order of date.
2885 records returned
Selection Bias Is Not a Good Reason for Advising More Than 5 Years of Adjuvant Hormonal Therapy for All Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy [CORRESPONDENCE]
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - November 18, 2009 Category: Cancer & Oncology Authors: Collette, Studer Tags: CORRESPONDENCE Source Type: journals
Biased Hormonal Therapy Duration Analysis Makes Results Uninterpretable [CORRESPONDENCE]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - November 18, 2009 Category: Cancer & Oncology Authors: Tangen, Goldman, Swanson, Thompson Tags: CORRESPONDENCE Source Type: journals
Hormones Plus Radiation Benefits Intermediate-Risk Prostate Cancer PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHICAGO (EGMN) - The addition of hormone therapy to radiation improves overall survival in men with locally confined prostate cancer, but the benefit appears to be concentrated in intermediate-risk patients,... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - November 18, 2009 Category: Cancer & Oncology Source Type: news
Targeted therapy of metastatic breast cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abstract Breast cancer is a heterogeneous disease characterised by a dysregulation of multiple pathways related to cell differentiation,
cell cycle control, apoptosis, angiogenesis and development of metastasis. Acting against these pathways provides therapeutic
targets for new targeted biologic therapies, which, in the future, might constitute a key for fighting cancer. The development
of molecular technology in recent years has allowed a further comprehension of these mutations and dysregulated pathways leading
to oncogenesis. New targeted biologic therapies will block essential functions of cancer cells a...
Source: Clinical and Translational Oncology - November 18, 2009 Category: Cancer & Oncology Tags: Clinical and Translational Oncology Source Type: journals
Mammographic Screening and Risk Factors for Breast CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Screening mammography can distort estimated effects in breast cancer risk models due to associations with other risk factors. Mammography information was available in the Nurses’ Health Study from 1988, and 1,815 incident breast cancers were accrued through 2000 among 55,625 women with risk factor data. Logistic models were fit for screening mammography, and inverse probability weighting was used to adjust parameters in an established breast cancer risk model. Approximately 80% of women in each 2-year follow-up period had screening mammograms, which were positively associated with history of benign breast disease, fa...
Source: American Journal of Epidemiology - November 18, 2009 Category: Epidemiology Authors: Cook, N. R., Rosner, B. A., Hankinson, S. E., Colditz, G. A. Tags: RESEARCH-ARTICLE Source Type: journals
Percentage Of Positive Biopsy Cores At The Onset Of Hormone Therapy For Prostate Cancer: Prognostic SignificanceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
UroToday.com - Accurate prediction of outcome after hormonal treatment for localized prostate cancer is important for patient counselling, follow-up, treatment planning and research protocol design. Few prognostic tools incorporating pre-therapeutic parameters are available to increase disease relapse predictions and survival. (Source: Prostate News From Medical News Today)
Source: Prostate News From Medical News Today - November 16, 2009 Category: Urology & Nephrology Tags: Prostate / Prostate Cancer Source Type: news
Percentage Of Positive Biopsy Cores At The Onset Of Hormone Therapy For Prostate Cancer: Prognostic SignificanceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
UroToday.com - Accurate prediction of outcome after hormonal treatment for localized prostate cancer is important for patient counselling, follow-up, treatment planning and research protocol design. Few prognostic tools incorporating pre-therapeutic parameters are available to increase disease relapse predictions and survival. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 16, 2009 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
Prostate cancer and its treatment with Iscucin®Populi—Introduction and case reports: der Merkurstab, Heft 3, 2009, pp. 255–261Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Background: Since prostate cancer is the most frequently diagnosed malignancy among males, the treatment of this disease becomes more and more important. A number of well-established forms of treatment are available in conventional medicine. These treatments are effective, but patients often suffer from considerable side effects (particularly concerning their sexuality), leading to an increased interest in complementary treatments.Objectives: Misteltoe therapy is a frequently applied complementary treatment in oncological practice, however, the state of knowledge regarding misteltoe therapy in prostate cancer is so far lim...
Source: European Journal of Integrative Medicine - November 13, 2009 Category: Complementary Medicine Authors: R. Kempenich, U. Meyer, M. Willeke Source Type: journals
Prognostic significance of global grading system of Gleason score in patients with prostate cancer with bone metastasisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
To investigate the influence of the revised Gleason grading system (GGS, revised at a consensus conference organized by the International Society of Urological Pathology in 2005) on prediction of prognosis for patients with prostate cancer with bone metastasis. Prostatic needle biopsy specimens from 113 patients with prostate cancer with bone metastasis were scored using the conventional GGS (CGGS), modified global GGS (MGGGS), and modified highest GGS (MHGGS). The patients were divided into two groups (Gleason score [le]7 and [ge]8) using each grading system. Prostate-specific antigen failure-free survival after hormone t...
Source: BJU International - November 12, 2009 Category: Urology & Nephrology Authors: Tsunehito Kambara, Tetsunari Oyama, Atsuki Segawa, Yoshitatsu Fukabori, Ken-Ichiro Yoshida Source Type: journals
Hormone Therapy Victims Win Important AppealEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
On November 2, 2009, the United States Court of Appeals for the Eighth Circuit issued its long-awaited decision in Scroggin v. Wyeth (Case No. 08-2555). The decision gives the green light for federal trials on Wyeth’s and Pfizer’s hormone therapy (http://www.hkllp.com/hormone-replacement-therapy/) drugs. In affirming judgment on a jury verdict of compensatory damages, the federal appellate court rejected the defendants’ claims that plaintiffs like Donna Scroggin cannot prove that hormone therapy caused their breast cancer. Erik Walker of Hissey Kientz, LLP (http://www.hkllp.com/) in Austin, Texas handled ...
Source: PRWeb: Medical Pharmaceuticals - November 11, 2009 Category: Pharmaceuticals Source Type: news
Hormone Therapy & Breast CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Coinciding with the decline of postmenopausal hormone therapy in the U.S., the rate of atypical ductal hyperplasia, a known risk factor for breast cancer, has dropped by more than 50 percent. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - November 11, 2009 Category: Consumer Health News Source Type: news
Comparison of aspiration and hormonal therapy for the treatment of ovarian cysts in cows.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Despite the variety of hormonal treating regimes used, a proportion of cows with cystic ovarian disease (COD) fail to be cured. The hypothesis of this study was that cyst aspiration would improve the curing rate and/or accelerate the resumption of ovarian activity in affected cows. In four groups of cows the following treatments were administered: Group A (n = 18) only cyst aspiration, Group AGP (n = 19) cyst aspiration and a combination of GnRH and PGF 2alpha , Group GP (n = 25) only GnRH and PGF 2alpha , and Group C (n = 15) untreated control. Cysts were aspirated without ultrasonographic guidance, using a new device...
Source: Acta Veterinaria Hungarica - November 11, 2009 Category: Veterinary Research Authors: Amiridis GS Tags: Acta Vet Hung Source Type: journals
As HRT Use Declines, Atypical Ductal Hyperplasia Rates Also FallEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Reductions in the use of postmenopausal hormone therapy may be one reason why the incidence of atypical ductal hyperplasia (ADH) has been declining in recent years. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2009 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Hormone Therapy for Prostate Cancer Induces the Metabolic Syndrome: is it Preventable?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Aim/introduction: The association between androgen deprivation therapy (ADT) for prostate cancer and metabolic syndrome has been reported, with insulin resistance as the key to its development. This is the first study to investigate the effect of metformin and lifestyle changes on the development of ADT-related metabolic syndrome. (Source: Clinical Oncology)
Source: Clinical Oncology - November 9, 2009 Category: Radiology Authors: J. Nobes, S. Langley, J. Money-Kyrle, R. Laing Tags: Abstracts Source Type: journals
Hormone replacement therapy and breast cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The use of postmenopausal hormone treatment has decreased over time in the United States, which scientists suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone therapy is linked to increased rates of non-malignant breast biopsies, and early and late stages of cancer. Atypical ductal hyperplasia is linked to the use of postmenopausal hormone therapy and its rates have decreased with the decline in use of this therapy," said researcher Tehillah Menes, M.D., who was the chief of breast service in the Department of Surgery at Elmhurst H...
Source: Medicineworld.org: New Article Alert - November 9, 2009 Category: Consumer Health News Source Type: info
Short-Term Versus Long-Term Hormone Therapy for Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This study provides some guidance. Journal Watch (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2009 Category: Consumer Health News Tags: Internal Medicine Source Type: news
Rates In Risk Factor For Breast Cancer, Atypical Ductal Hyperplasia, Fell In Line With Hormone Therapy Decline, US StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers in the US found that the decline in use of postmenopausal hormone therapy may partly explain the fall in incidence of a known risk factor for breast cancer, atypical ductal hyperplasia. They also said their findings support the idea that low and high grade breast cancers develop via different pathways and thereby clarify the role that hormone therapy may play in increasing the rates of breast cancer. (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - November 9, 2009 Category: Cancer & Oncology Tags: Breast Cancer Source Type: news
New Key To The Puzzle Of Hormone Therapy And Breast Cancer Uncovered By ScientistsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer. (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - November 9, 2009 Category: Cancer & Oncology Tags: Breast Cancer Source Type: news
New Key To The Puzzle Of Hormone Therapy And Breast Cancer Uncovered By ScientistsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 9, 2009 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Rates In Risk Factor For Breast Cancer, Atypical Ductal Hyperplasia, Fell In Line With Hormone Therapy Decline, US StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers in the US found that the decline in use of postmenopausal hormone therapy may partly explain the fall in incidence of a known risk factor for breast cancer, atypical ductal hyperplasia. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 9, 2009 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Scientists uncover new key to the puzzle of hormone therapy and breast cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(American Association for Cancer Research) The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 9, 2009 Category: Global & Universal Source Type: news
New Key To Puzzle Of Hormone Therapy And Breast CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 9, 2009 Category: Science Source Type: news
Atypical ductal hyperplasia linked to hormone therapy useEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Postmenopausal hormonal therapy is associated with an increased risk for atypical ductal hyperplasia in patients with or without associated breast cancer, US researchers report. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - November 9, 2009 Category: Cancer & Oncology Source Type: news
Hormone Therapy and Breast Cancer Precursor Link StudiedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A decline in the use of postmenopausal hormone treatment in the past decade may be a factor in the
decreased incidence of atypical ductal hyperplasia, a suspected precursor of some breast cancers, according to a
study in the November issue of Cancer Epidemiology, Biomarkers & Prevention. (Source: Modern Medicine)
Source: Modern Medicine - November 9, 2009 Category: Journals (General) Source Type: info
Atypical ductal hyperplasia linked to hormone therapy useEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Postmenopausal hormonal therapy is associated with an increased risk for atypical ductal hyperplasia in patients with or without associated breast cancer, US researchers report. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - November 9, 2009 Category: Cancer & Oncology Source Type: news
Extra hormone therapy improves survival in radiation-treated prostate cancer patientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Adding 4 months of hormone therapy to standard radiotherapy for prostate cancer increases overall patient survival rates, suggest results from the largest phase III randomized trial of its kind. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - November 7, 2009 Category: Cancer & Oncology Source Type: news
Extra hormone therapy improves survival in radiation-treated prostate cancer patientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Adding 4 months of hormone therapy to standard radiotherapy for prostate cancer increases overall patient survival rates, suggest results from the largest phase III randomized trial of its kind. (Source: MedWire News - Prostate Cancer)
Source: MedWire News - Prostate Cancer - November 7, 2009 Category: Cancer & Oncology Source Type: news
Area under the curve of TSH after levothyroxine withdrawal versus administration of recombinant human TSH (rhTSH): possible implications for tumor growthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CONCLUSIONS: Surprising difference in the TSH AUC was demonstrated between rhTSH administration versus L-T4 withdrawal.OBJETIVO: A suspensão de levotiroxina (L-T4) por algumas semanas resulta em exposição prolongada ao TSH elevado. Em contraste, a administração do TSH recombinante (rhTSH) promove um curto período de hipertirotropinemia. O objetivo deste estudo foi comparar a área sob a curva (do inglês "area under the curve", AUC) do TSH obtida após suspensão da L-T4 versus a administração do rhTSH. MÉTODOS: Trinta pacientes receberam 0,9 mg de rhTSH por dois dias consecutivos, e 64 foram preparados com suspen...
Source: Arquivos Brasileiros de Endocrinologia e Metabologia - November 6, 2009 Category: Endocrinology Source Type: journals
Hormone Therapy May Lower Mortality in Younger WomenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Younger postmenopausal women on hormone replacement therapy may have a lower risk of mortality than
women undergoing no treatment, according to the results of a Bayesian meta-analysis published in the November issue
of the American Journal of Medicine. (Source: Modern Medicine)
Source: Modern Medicine - November 6, 2009 Category: Journals (General) Source Type: info
Short-Term Hormone Therapy Added to Radiation Increases Survival for Medium-Risk, But Not Low-Risk, Prostate Cancer PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHICAGO, Nov. 2 /PRNewswire-USNewswire/ -- Short-term hormone
therapy given prior to and during radiation treatment to
medium-risk prostate cancer patients increases their chance of
living longer, compared to those who receive radiation... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 5, 2009 Category: Pharmaceuticals Source Type: clinical trials
Early menopausal hormone therapy may increase breast cancer riskEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The timing of estrogen-progestagen menopausal hormone therapy initiation transiently modulates the risk for breast cancer, study findings indicate. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - November 4, 2009 Category: Cancer & Oncology Source Type: news
Women with breast cancer have low vitamin D levels, scientists discoverEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(NaturalNews) At the American Society of Clinical Oncology's Breast Cancer Symposium held in San Francisco recently, researchers from the University of Rochester Medical Center made an announcement that at first glance may seem startling -- at least it may startle people who are unaware of the preventive and healing power of nutrients. When they studied 166 women undergoing treatment for breast cancer, the scientists found the vast majority, about 70 percent, had something other than their cancer in common: they had very low levels of vitamin D in their blood. What's more, women whose disease had progressed to late-stage (...
Source: NaturalNews.com - November 4, 2009 Category: Consumer Health Advice Source Type: news
Is Prostate Cancer Overtreated?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The majority of men with prostate cancer can be spared from anti-hormone therapy -- and all of its side effects, including impotence, hot flashes, and liver problems, researchers say. (Source: WebMD Health)
Source: WebMD Health - November 3, 2009 Category: Consumer Health News Source Type: news
Landmark Study on Hormone Therapy in Low-Risk Prostate Cancer: Results Now InEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In a repudiation of widespread practice, a landmark trial indicates that short-term hormone therapy does not improve survival in men with low-risk disease. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 3, 2009 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Short-Term Hormone Therapy And Intermediate Dose Radiation Increases Survivial For Early Stage Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone, according to a Radiation Therapy Oncology Group (RTOG) study, the larges (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 3, 2009 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
Short-term Hormone Therapy Added To Radiation Increases Survival For Medium-risk, But Not Low-risk, Prostate Cancer PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 3, 2009 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
Hormone Therapy Can Help Some With Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Hormone Therapy Can Help Some With Prostate CancerCategory: Health NewsCreated: 11/2/2009 2:10:00 PMLast Editorial Review: 11/3/2009 (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 3, 2009 Category: Cancer & Oncology Source Type: consumer
Hormone Therapy Can Help Some With Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Hormone Therapy Can Help Some With Prostate CancerCategory: Health NewsCreated: 11/2/2009 2:10:00 PMLast Editorial Review: 11/3/2009 (Source: MedicineNet Senior Health General)
Source: MedicineNet Senior Health General - November 3, 2009 Category: Geriatrics Source Type: consumer
Hormone Therapy Can Help Some With Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Hormone Therapy Can Help Some With Prostate CancerCategory: Health NewsCreated: 11/2/2009 2:10:00 PMLast Editorial Review: 11/3/2009 (Source: MedicineNet Menopause General)
Source: MedicineNet Menopause General - November 3, 2009 Category: Primary Care Source Type: consumer
Hormone Therapy Can Help Some With Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Hormone Therapy Can Help Some With Prostate CancerCategory: Health NewsCreated: 11/2/2009 2:10:00 PMLast Editorial Review: 11/3/2009 (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - November 3, 2009 Category: Primary Care Source Type: consumer
Image guided dose escalated prostate radiotherapy: still room to improveEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions:
IGRT to 79.8 Gy results in favourable rates of late toxicity compared with published non-IGRT treated cohorts. Future avenues of investigation for toxicity reduction include IMRT, margin reduction, and dose modulation targeted to sites of disease burden. Further work is required to maximize efficacy beyond that achieved through radiation dose escalation alone. (Source: Radiation Oncology)
Source: Radiation Oncology - November 3, 2009 Category: Cancer & Oncology Authors: Jarad MartinAndrew BayleyRobert BristowPeter ChungMary GospodarowiczCynthia MenardMichael MilosevicTara RosewallPadraig WardeCharles Catton Source Type: journals
Early menopausal hormone therapy may increase breast cancer riskEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The timing of estrogen-progestagen menopausal hormone therapy initiation transiently modulates the risk for breast cancer, study findings indicate. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - November 3, 2009 Category: Cancer & Oncology Source Type: news
Postmenopausal hormone therapy and cognition: effects of timing and treatment type.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion 'Early start' of estrogen-only hormone therapy was associated with reduced risk of global cognitive decline, and 'early start' estrogen-only and estrogen/progestogen hormone therapies showed increased risks of general memory decline. Even though this study did not have the power to discriminate between minor and mixed effects, it suggests that cognitive effects of hormone therapies may be mixed, depending on cognitive domain and timing of use/type of preparation.
PMID: 19886816 [PubMed - as supplied by publisher] (Source: Climacteric)
Source: Climacteric - November 3, 2009 Category: Geriatrics Authors: Khoo SK, O'Neill S, Byrne G, King R, Travers C, Tripcony L Tags: Climacteric Source Type: journals
Insomnia in Japanese peri- and postmenopausal women.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions Insomnia in Japanese peri- and postmenopausal women correlates more strongly with depressed mood than with vasomotor symptoms. Cessation of smoking may improve the women's sleep quality, and hormone therapy and nightly hypnotics are both effective treatments.
PMID: 19886814 [PubMed - as supplied by publisher] (Source: Climacteric)
Source: Climacteric - November 3, 2009 Category: Geriatrics Authors: Terauchi M, Obayashi S, Akiyoshi M, Kato K, Matsushima E, Kubota T Tags: Climacteric Source Type: journals
Postmenopausal hormone therapy and regional brain volumes: the whims-mri studyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Neurology)
Source: Neurology - November 2, 2009 Category: Neurology Authors: den Heijer, T., van der Lijn, F., Niessen, W. J., Breteler, M. M.B. Tags: CORRESPONDENCE Source Type: journals
Hormone Therapy Can Help Some with Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
But often not needed for early-stage patients, long-running study shows Source: HealthDay
Related MedlinePlus Topics: Hormones, Prostate Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 2, 2009 Category: Consumer Health News Source Type: consumer
Addition of hormone therapy to radiation therapy improved OS in patients
with prostate cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: HemOncToday.com)
Source: HemOncToday.com - November 2, 2009 Category: Cancer & Oncology Source Type: info
Five-year Follow-up of Health-related Quality of Life after Intensity-modulated Radiation Therapy for Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions
IMRT can provide the possibility to deliver a high irradiation dose to the prostate with satisfactory functional outcomes for long-term periods. (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - November 2, 2009 Category: Cancer & Oncology Authors: Namiki, S., Ishidoya, S., Ito, A., Tochigi, T., Numata, I., Narazaki, K., Yamada, S., Takai, Y., Arai, Y. Tags: Original Articles Source Type: journals
ASTRO: Hormone therapy+dose radiation increases survival with prostate cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone, according to a study presented today at the American Society for Radiation Oncology (ASTRO) annual meeting. (Source: Health Imaging News)
Source: Health Imaging News - November 2, 2009 Category: Radiology Tags: Latest News Source Type: news
